These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 13018806)

  • 1. [Anatomical alterations of intrahepatic blood vessels in Morgagni-Laennec cirrhosis].
    MONTAGNANI CA; PACI G
    Boll Soc Ital Biol Sper; 1952 Jul; 28(7):1439-41. PubMed ID: 13018806
    [No Abstract]   [Full Text] [Related]  

  • 2. [Morgagni-Laennec cirrhosis; clinicostatistical study of 137 cases].
    LUSIANI GB; SALVI A
    Omnia Ther Suppl; 1955; 33(3-4):129-74. PubMed ID: 13289007
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hemoglobin metabolism in Morgagni-Laennec cirrhosis].
    LATTANZI A
    Riv Gastroenterol; 1950; 2(5):241-67. PubMed ID: 14817009
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of hepatic artery ligation on ascites due to laennec cirrhosis; report of two cases.
    SMITH JC; MCNEALY RW; ZAUS EA
    AMA Arch Surg; 1953 Mar; 66(3):344-55. PubMed ID: 13030061
    [No Abstract]   [Full Text] [Related]  

  • 5. [Modifications of glucides metabolism in Morgagni-Laennec cirrhosis].
    SCOTTI G
    Riv Gastroenterol; 1952; 4(6):265-84. PubMed ID: 13014916
    [No Abstract]   [Full Text] [Related]  

  • 6. [Sodium retention as a cause of ascites in Morgagni-Laennec cirrhosis].
    D'AMICO G
    Arch Patol Clin Med; 1956; 32(5):353-73. PubMed ID: 13341373
    [No Abstract]   [Full Text] [Related]  

  • 7. [Liver cirrhosis. II. Hemolysis in the pathogenesis of the normocytic and macrocytic anemia of Morgagni-Laennec cirrhosis; hemoglobin metabolism and variations induced by lipotropic factor therapy].
    FALZOY M; D'ANTUONO G; ORLANDO E
    G Clin Med; 1952 Jun; 33(6):575-90. PubMed ID: 12989544
    [No Abstract]   [Full Text] [Related]  

  • 8. Laennec cirrhosis, its histogenesis, with special reference to the role of angiogenesis.
    MOSCHCOWITZ E
    Arch Pathol (Chic); 1948 Feb; 45(2):187-215. PubMed ID: 18915217
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fever in Morgagni-Laennec cirrhosis: contribution in clinical statistics].
    BASTAGLI D; ORLANDI G
    G Clin Med; 1949 Sep; 30(9):726-42. PubMed ID: 15394662
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hemodynamic and oximetric changes in portal cirrhosis].
    PURRIEL P; ARCOS PEREZ M; YANNICELLI E; POMMERENCK C
    Rev Med Chil; 1961 Oct; 89():794-7. PubMed ID: 14489257
    [No Abstract]   [Full Text] [Related]  

  • 11. Ligation of the hepatic artery in portal cirrhosis; report of seven cases.
    GARCIA G; SARMIENTO AP
    Acta Med Philipp; 1952; 9(1):31-40. PubMed ID: 13065007
    [No Abstract]   [Full Text] [Related]  

  • 12. Different hemodynamic patterns of alcoholic and viral endstage cirrhosis: analysis of explanted liver weight, degree of fibrosis and splanchnic Doppler parameters.
    Bolognesi M; Sacerdoti D; Mescoli C; Bombonato G; Cillo U; Merenda R; Giacomelli L; Merkel C; Rugge M; Gatta A
    Scand J Gastroenterol; 2007 Feb; 42(2):256-62. PubMed ID: 17327946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrahepatic spontaneous retrograde portal flow in patients with cirrhosis of the liver: reversal by food intake.
    Tochio H; Kudo M; Nishiuma S; Okabe Y
    AJR Am J Roentgenol; 2001 Nov; 177(5):1109-12. PubMed ID: 11641182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on liver cirrhosis. III. Megaloblastic anemia during Morgagni-Laennec cirrhosis].
    FALZOI M; MAGNANI B
    Prog Med (Napoli); 1953 Aug; 9(16):494-501. PubMed ID: 13112283
    [No Abstract]   [Full Text] [Related]  

  • 15. [Significance of changes in the portal lymph nodes in liver cirrhosis of Morgagni-Laënnec; liver cirrhosis and portal lymph circulation].
    CECCHI G; INFRANZI A
    Riforma Med; 1955 Jun; 69(23):626-36. PubMed ID: 13246461
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatic circulation in cirrhosis.
    Huet PM; Villeneuve JP; Pomier-Layrargues G; Marleau D
    Clin Gastroenterol; 1985 Jan; 14(1):155-68. PubMed ID: 3886212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Previous jaundice in Morgagni-Läennec liver cirrhosis].
    GALLO V
    Minerva Med; 1948 Nov; 39(46 Pt 2):519-23. PubMed ID: 18104958
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinicostatistical study on 308 cases of Morgagni-Laennec liver cirrhosis].
    NICROSINI F
    G Clin Med; 1958 Aug; 39(8):1171-204. PubMed ID: 13609995
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of intrahepatic portal-systemic shunts in the reduction of portal blood supply to liver cells in cirrhosis.
    Chin N; Ohnishi K; Iida S; Nomura F
    Am J Gastroenterol; 1988 Jul; 83(7):718-22. PubMed ID: 3381802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New etiopathogenetic concepts and modern therapy of Morgagni-Laënnec liver cirrhosis].
    CAMPANA C
    Policlinico Prat; 1949 Jan; 56(4):97-111. PubMed ID: 18109675
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.